Page last updated: 2024-10-27

flurbiprofen and Carcinoma 256, Walker

flurbiprofen has been researched along with Carcinoma 256, Walker in 2 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Powles, TJ2
Frank, GJ1
Millar, JL2

Other Studies

2 other studies available for flurbiprofen and Carcinoma 256, Walker

ArticleYear
Interactions of cytotoxic and anti-inflammatory agents on normal and neoplastic tissue.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 6

    Topics: Animals; Carcinoma 256, Walker; Cell Survival; Chlorambucil; Flurbiprofen; Hematopoietic Stem Cells;

1980
Non-steroidal anti-inflammatory drugs and cytotoxics.
    Cancer treatment reviews, 1979, Volume: 6 Suppl

    Topics: Animals; Bone Marrow; Carcinoma 256, Walker; Chlorambucil; Digestive System; Flurbiprofen; Indometha

1979